Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital with Nanjing Medical University
The First Affiliated Hospital with Nanjing Medical University
CRISPR Therapeutics
Roswell Park Cancer Institute
Adicet Therapeutics
CARGO Therapeutics
Thomas Jefferson University
Gamida Cell ltd